Safety and efficacy of neoadjuvant therapy with tislelizumab plus chemotherapy for locally advanced head and neck squamous cell carcinoma: a single-arm, retrospective study

Related articles

1. Phase II trial of chemotherapy, cetuximab and erlotinib in patients with metastatic or recurrent squamous cell carcinoma of the head and neck

   This article has 12 authors:

   1. Aarti Bhatia
   2. Ranee Mehra
   3. Jessica Bauman
   4. Saad A. Khan
   5. Wei Wei
   6. Veronique Neumeister
   7. Teresa Sandoval-Schaefer
   8. R. Katherine Alpaugh
   9. Miriam Lango
   10. David L. Rimm
   11. John A. Ridge
   12. Barbara Burtness

2. Comparative Analysis of Clinical Outcomes Between Neoadjuvant Chemoimmunotherapy and Neoadjuvant Chemoradiotherapy in Patients with Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Retrospective Study

   This article has 10 authors:

   1. Xue Yan
   2. Ying Peng
   3. Peng Mo
   4. Liuyu Li
   5. Weijing Jiang
   6. Wenzhen Zhang
   7. Yuanji Xu
   8. Miaoyi Su
   9. Yongshi Shen
   10. Zhichao Fu

3. Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial

   This article has 22 authors:

   1. Michael Ghadimi
   2. Uwe Pelzer
   3. Marc G. Besselink
   4. Jens Siveke
   5. Ralph Telgmann
   6. Rickmer Braren
   7. Hanneke Wilmink
   8. Marie Crede
   9. Alexander Koenig
   10. Ute Koenig
   11. Sven Thorsten Liffers
   12. Kai Antweiler
   13. Bas Uijterwijk
   14. Hanna Seppanen
   15. Arno Nordin
   16. Pauli Puolakkainen
   17. Olav F. Dajani
   18. Knut Jørgen Labori
   19. Mia Johansson
   20. Svein Olav Bratlie
   21. Tim Friede
   22. Peter Jo